Are neutrophil to lymphocyte ratio and platelet to lymphocyte ratio a useful markers to predict the severity of COPD and future acute exacerbation?
O. Asma (Sousse, Tunisia), A. Sana (Sousse, Tunisia), K. Asma (Sousse, Tunisia), B. Wafa (Sousse, Tunisia), B. Rahma (Kairouan, Tunisia), K. Ameni (Kairouan, Tunisia), G. Imene (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia)
Source: International Congress 2022 – Exacerbations in COPD: biomarkers and management
Session: Exacerbations in COPD: biomarkers and management
Session type: Thematic Poster
Number: 203
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Asma (Sousse, Tunisia), A. Sana (Sousse, Tunisia), K. Asma (Sousse, Tunisia), B. Wafa (Sousse, Tunisia), B. Rahma (Kairouan, Tunisia), K. Ameni (Kairouan, Tunisia), G. Imene (Sousse, Tunisia), A. Ahmed (Sousse, Tunisia), H. Abdelaziz (Sousse, Tunisia). Are neutrophil to lymphocyte ratio and platelet to lymphocyte ratio a useful markers to predict the severity of COPD and future acute exacerbation?. 203
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|